May 2026
1. RODRIGUEZ MI, Fuerst M, Schrote K
   Management of Spontaneous Abortion Among Commercially Insured Individuals in the United States After Dobbs v Jackson.
   JAMA. 2026 May 18:e266344. doi: 10.1001/jama.2026.6344.
   

   >> Share

   
   January 2026
2. DILEK S, Rosen J, Levashkevich A, Sharfstein JM, et al
   The US Food and Drug Administration's Regulation of Mifepristone.
   JAMA. 2026 Jan 12. doi: 10.1001/jama.2025.23091.
   

   >> Share

   
   November 2025
3. PANT S
   ACOG Issues Contraception Access Guidance.
   JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19726.
   

   >> Share

   
   June 2025
4. MEAIDI A, Yonis HGH
   Hormonal Contraception and Venous Thromboembolism Risk-Reply.
   JAMA. 2025 Jun 12. doi: 10.1001/jama.2025.5021.
   

   >> Share

   
   
5. LIDEGAARD O
   Hormonal Contraception and Venous Thromboembolism Risk.
   JAMA. 2025 Jun 12. doi: 10.1001/jama.2025.5018.
   

   >> Share

   
   May 2025
6. AS-SANIE S, Mackenzie SC, Morrison L, Schrepf A, et al
   Endometriosis: A Review.
   JAMA. 2025 May 5. doi: 10.1001/jama.2025.2975.
   

   >> Share

   
   February 2025
7. YONIS HGH, Morch LS, Lokkegaard E, Kragholm K, et al
   Contemporary Hormonal Contraception and Risk of Venous Thromboembolism.
   JAMA. 2025 Feb 10:e2428778. doi: 10.1001/jama.2024.28778.
   

   >> Share

   
   
8. ANDERER S
   Permanent Contraception Procedures Increase Among Young Adults Post Dobbs.
   JAMA. 2025 Feb 7. doi: 10.1001/jama.2025.0241.
   

   >> Share

   
   October 2024
9. GROSSMAN D, Kinsey ET
   Over-the-Counter Oral Contraceptives.
   JAMA. 2024 Oct 9. doi: 10.1001/jama.2024.16474.
   

   >> Share

   
   September 2024
10. LYNCH HF, Lurie P, Cohen IG
    Checks and Balances on FDA's Authority.
    JAMA. 2024;332:705-706.
    

    >> Share

    
    August 2024
11. GOODWIN MB, Whelan AM, Gostin LO
    Food and Drug Administration v Alliance for Hippocratic Medicine-A Cautious Win for Reproductive Health Care and FDA Authority.
    JAMA. 2024;332:453-454.
    

    >> Share

    
    July 2024
12. QATO DM, Guadamuz JS, Myerson R
    Changes in Emergency Contraceptive Fills After Massachusetts' Statewide Standing Order.
    JAMA. 2024 Jul 2:e2411715. doi: 10.1001/jama.2024.11715.
    

    >> Share

    
    June 2024
13. RALPH LJ, Baba CF, Biggs MA, McNicholas C, et al
    Comparison of No-Test Telehealth and In-Person Medication Abortion.
    JAMA. 2024 Jun 24:e2410680. doi: 10.1001/jama.2024.10680.
    

    >> Share

    
    
14. HARRIS E
    Receiving Abortion Medication Through Mail Was Safe, Effective.
    JAMA. 2024 Jun 7. doi: 10.1001/jama.2024.10330.
    

    >> Share

    
    May 2024
15. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
    The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    JAMA. 2024;331:1748-1760.
    

    >> Share

    
    
16. ESPEY E, Hailstorks T, Hofler L
    Understanding the Impacts of the Supreme Court Case FDA v Alliance for Hippocratic Medicine.
    JAMA. 2024;331:1529-1530.
    

    >> Share

    
    April 2024
17. HARRIS E
    Over-the-Counter Birth Control Pill Now Available in US.
    JAMA. 2024;331:1354.
    

    >> Share

    
    
18. HARRIS E
    Use of Progestogen Tied to Higher Chance of Benign Brain Tumor.
    JAMA. 2024 Apr 19. doi: 10.1001/jama.2024.5923.
    

    >> Share

    
    March 2024
19. FERNANDEZ LYNCH H, Kesselheim AS
    The FDA in the Crosshairs-Science, Politics, and Abortion.
    JAMA. 2024 Mar 25. doi: 10.1001/jama.2024.2229.
    

    >> Share

    
    
20. AIKEN ARA, Wells ES, Gomperts R, Scott JG, et al
    Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision.
    JAMA. 2024 Mar 25:e244266. doi: 10.1001/jama.2024.4266.
    

    >> Share

    
    October 2023
21. MEEGAN MA
    Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access.
    JAMA. 2023 Oct 26. doi: 10.1001/jama.2023.21591.
    

    >> Share

    
    September 2023
22. HARRIS E
    Blot Clot Risk Higher When Pain Relievers Used With Hormonal Contraception.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17823.
    

    >> Share

    
    
23. FLEURANT E, Mokashi M, Simon MA
    Over-the-Counter Progestin-Only Oral Contraceptives.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17781.
    

    >> Share

    
    August 2023
24. HARRIS E
    FDA Greenlights First Over-the-Counter Oral Birth Control.
    JAMA. 2023;330:585.
    

    >> Share

    
    July 2023
25. JUGL S, Winterstein AG
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
    JAMA. 2023;330:378.
    

    >> Share

    
    
26. MEAIDI A, Torp-Pedersen C, Morch LS
    Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems-Reply.
    JAMA. 2023;330:378-379.
    

    >> Share

    
    
27. BOOS EW, Horta M, Thompson I, Dusetzina SB, et al
    Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
    JAMA. 2023 Jul 21. doi: 10.1001/jama.2023.13628.
    

    >> Share

    
    
28. BRANDI K, Upadhya KK, Teal SB
    Over-the-Counter Oral Contraception as an Opportunity to Reduce Contraceptive Access Inequity.
    JAMA. 2023 Jul 14. doi: 10.1001/jama.2023.10825.
    

    >> Share

    
    June 2023
29. RUBIN R
    Over-the-Counter Birth Control Pill Could Be Available in the US by Year's End.
    JAMA. 2023;329:2009-2010.
    

    >> Share

    
    
30. GLUCK AR
    The Mifepristone Case and the Legitimacy of the FDA.
    JAMA. 2023 Jun 2. doi: 10.1001/jama.2023.8712.
    

    >> Share

    
    April 2023
31. AARON DG, Brown TR, Sinha MS
    Court Intrusion Into Science and Medicine-the Mifepristone Decisions.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.7790.
    

    >> Share

    
    March 2023
32. MEAIDI A, Torp-Pedersen C, Lidegaard O, Morch LS, et al
    Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
    JAMA. 2023;329:935-937.
    

    >> Share

    
    
33. AVERBACH S, Kully G, Hinz E, Dey A, et al
    Early vs Interval Postpartum Intrauterine Device Placement: A Randomized Clinical Trial.
    JAMA. 2023;329:910-917.
    

    >> Share

    
    
34. HARRIS E
    On-Demand Male Contraceptive Compound Promising in Mouse Study.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2888.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share